OFT Accuses Reckitt Of Limiting Generic Access

Law360, New York (February 23, 2010, 1:06 PM EST) -- The U.K. Office of Fair Trading has alleged that Reckitt Benckiser Group PLC abused its dominant market position by withdrawing its National Health Service supply of Gaviscon heartburn medication before the NHS would have allowed pharmacies to offer generic alternatives of the treatment.

The regulator alleged Tuesday that Reckitt Benckiser timed the withdrawal of NHS packs of Gaviscon Original Liquid from the NHS prescription channel so it would occur before the publication of the generic name for the product.

That way, when doctors searched for Gaviscon...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.